Molecular model of the interaction between nimesulide and human cyclooxygenase-2.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Rheumatology

• Publication date

  1999-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/RHEUMATOLOGY/38.SUPPL_1.14PMID 10369401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1997influential reference
• The SWISS-PROT protein sequence data bank and its supplement TrEMBL

  1997cited by this paper
• The cyclooxygenase-2 stucture: new drugs for an old target?

  1996cited by this paper
• Role of Val509 in Time-dependent Inhibition of Human Prostaglandin H Synthase-2 Cyclooxygenase Activity by Isoform-selective Agents*

  1996cited by this paper
• Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2

  1996cited by this paper
• A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors*

  1996cited by this paper
• Synthesis and use of iodinated nonsteroidal antiinflammatory drug analogs as crystallographic probes of the prostaglandin H2 synthase cyclooxygenase active site.

  1996cited by this paper
• Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents

  1996influential reference
• Activity of nimesulide on constitutive and inducible cyclooxygenases.

  1995cited by this paper
• The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase

  1995cited by this paper
• Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity.

  1995cited by this paper
• Acetylation of human prostaglandin endoperoxide synthase-2 (cyclooxygenase-2) by aspirin.

  1994cited by this paper
• The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1

  1994cited by this paper
• Prostaglandin H synthase

  1993cited by this paper
• Human cyclooxygenase-2 cDNA.

  1992cited by this paper
• Automated docking with grid‐based energy evaluation

  1992cited by this paper
• A rapid finite difference algorithm, utilizing successive over‐relaxation to solve the Poisson–Boltzmann equation

  1991cited by this paper
• Automated docking of substrates to proteins by simulated annealing

  1990influential reference
• Tyrosine 385 of prostaglandin endoperoxide synthase is required for cyclooxygenase catalysis.

  1990cited by this paper
• Multiple sequence alignment with hierarchical clustering.

  1988cited by this paper
• A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.

  1985cited by this paper
• A COMPUTATIONAL PROCEDURE FOR DETERMINING ENERGETICALLY FAVORABLE BINDING SITES ON BIOLOGICALLY IMPORTANT MACROMOLECULES

  1985cited by this paper
• The Cambridge Crystallographic Data Centre: computer-based search, retrieval, analysis and display of information

  1979cited by this paper
• The Protein Data Bank: a computer-based archival file for macromolecular structures.

  1977cited by this paper
• 4-nitro-2-phenoxymethanesulfonanilide (R-805): a chemically novel anti-inflammatory agent.

  1976cited by this paper
• Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

  1971cited by this paper
• \the Protein Data Bank: a Computer-based Archival Le for Macromolecular Structures,"

  year unknowninfluential reference

• Anticancer effect of the antirheumatic drug leflunomide on oral squamous cell carcinoma by the inhibition of tumor angiogenesis

  2025cites this paper
• Diagnosis and treatment of dorsalgia in outpatient practice

  2024cites this paper
• НИМЕСУЛИД ПРИ ЛЕЧЕНИИ ОСТРОЙ И ХРОНИЧЕСКОЙ БОЛИ В КЛИНИЧЕСКОЙ ПРАКТИКЕ

  2017cites this paper
• Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease

  2016cites this paper
• EVALUATION OF THE IN VITRO ANTI-INFLAMMATORY ACTIVITY OF THE ETHANOLEXTRACT FROM THE SEEDS OF ENTADA PURSAETHA DC

  2016cites this paper
• Dual Cyclooxygenase and Carbonic Anhydrase Inhibition by Nonsteroidal Anti-Inflammatory Drugs for the Treatment of Cancer.

  2015cites this paper
• 58 – Immunosuppressives: Cyclosporine, cyclophosphamide, azathioprine, mycophenolate mofetil

  2015cites this paper
• IN SILICO AND IN VITRO EXPLORATION OF ANTI- INFLAMMATORY ACTIVITY OF ENTADA PURSAETHA BY MOLECULAR DOCKING STUDIES

  2014cites this paper
• Synthesis of 6-(4-methanesulphonamidophenyl)-substituted dihydropyridazinone/ phthalazinone derivatives as potent anti-inflammatory and analgesic agents

  2014cites this paper
• Rapeseed oil-rich diet alters in vitro menadione and nimesulide hepatic mitochondrial toxicity.

  2013cites this paper
• Rapeseed oil-rich diet alters in vitro menadione and nimesulide hepatic 1 mitochondrial toxicity 2 3

  2013cites this paper
• Teriflunomide for the treatment of multiple sclerosis.

  2013cites this paper
• Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis

  2013cites this paper
• Nimesulide interaction with membrane model systems: are membrane physical effects involved in nimesulide mitochondrial toxicity?

  2011influential citation
• Immunosuppressives (chlorambucil, cyclosporine, cyclophosphamide [Cytoxan], azathioprine [Imuran], mofetil, tacrolimus)

  2011cites this paper
• Formulation of nimesulide floating microparticles using low-viscosity hydroxypropyl methylcellulose.

  2010cites this paper
• Treatment of Connective Tissue Disease-Associated Interstitial Lung Disease

  2009cites this paper
• Combination therapy for autoimmune diseases: the rheumatoid arthritis model

  2009cites this paper
• Nimesulide - Actions and Uses

  2008cites this paper
• Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs.

  2008cites this paper
• CDAI (clinical disease activity index) in rheumatoid arthritis: cut-off values for classification into different grades of disease activity

  2007cites this paper
• Comparative toxicity studies in birds using nimesulide and diclofenac sodium.

  2006cites this paper
• The effects of leflunomide on clinical parameters and serum levels of IL-6, IL-10, MMP-1 and MMP-3 in patients with resistant rheumatoid arthritis.

  2006cites this paper
• Basic immunosuppressive drugs outside solid organ transplantation

  2006cites this paper
• Hepatoprotective effect of aqueous extract of Phyllanthus niruri on nimesulide-induced oxidative stress in vivo.

  2006cites this paper
• DOES MATRIX METALLOPROTEINASE ACTIVITY PREDICT SEVERITY OF ACUTE PANCREATITIS?

  2006cites this paper
• Pharmacological properties of nimesulide

  2005cites this paper
• Chronic Cutaneous Lupus Erythematosus

  2005cites this paper
• Immunosuppressive Drugs in Cutaneous Lupus Erythematosus

  2005cites this paper
• Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.

  2004cites this paper
• Pharmacology and toxicology of COX-2 inhibitors

  2004cites this paper
• Antiviral drugs: Inside the envelope

  2004cites this paper
• Mycophenolate mofetil reduces deterioration of renal function in patients with chronic allograft nephropathy: A follow-up study by the Spanish Cooperative Study Group of Chronic Allograft Nephropathy12

  2004cites this paper
• A COX-2 inhibitor, nimesulide, inhibits chemically-induced rat tongue carcinogenesis through suppression of cell proliferation activity and COX-2 and iNOS expression.

  2003cites this paper
• A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385*

  2003cites this paper
• Theoretical studies on the inhibition mechanism of cyclooxygenase-2. Is there a unique recognition site?

  2003cites this paper
• Therapeutic aspects of autoimmune diseases of the skin

  2003cites this paper
• Leflunomide for the treatment of rheumatoid arthritis.

  2002cites this paper
• Interferon-β for treatment of rheumatoid arthritis?

  2002cites this paper
• Mechanisms of NSAID-Induced Hepatotoxicity

  2002cites this paper
• Mechanisms of NSAID-Induced Hepatotoxicityon Nimesulide

  2002cites this paper
• COX-1 and COX-2 inhibitors.

  2001cites this paper
• The Year in Review: Rheumatology

  2001cites this paper
• Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities

  2000cites this paper
• Biochemistry of Cyclooxygenase (COX)-2 Inhibitors and Molecular Pathology of COX-2 in Neoplasia

  2000cites this paper
• Overview of nimesulide.

  1999cites this paper